Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04194242
What this trial is testing

The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Sunshine Lake Pharma Co., Ltd. 64
Not applicableStudy completedNCT07837323
What this trial is testing

Flaxseed Oil, Olive Oil, and Their Combination on Hepatic and Metabolic Outcomes in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease

Who this might be right for
Liver EnzymesGlucose LevelsLipid Profile
University of Lahore 112
Not applicableStudy completedNCT03786523
What this trial is testing

Time Restricted Feeding on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Nanfang Hospital, Southern Medical University 88
Not applicableLooking for participantsNCT06124261
What this trial is testing

Androgens and NAFLD Longitudinal Cohort Study

Who this might be right for
PCOSNAFLDNASH
University of California, San Francisco 150
Not applicableLooking for participantsNCT07093346
What this trial is testing

The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease (NAFLD)MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+7 more
University of Nottingham 45
Testing effectiveness (Phase 2)Looking for participantsNCT07198386
What this trial is testing

Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
NASH
Cascade Pharmaceuticals, Inc 120
Not applicableStudy completedNCT01548079
What this trial is testing

Ursodeoxycholic Acid in Bariatric Surgery

Who this might be right for
Non-alcoholic Fatty Liver DiseaseMorbid Obesity
Sahlgrenska University Hospital 40
Not applicableLooking for participantsNCT06890169
What this trial is testing

OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities

Who this might be right for
Obesity and Type 2 DiabetesNAFLD - Non-Alcoholic Fatty Liver DiseaseHypertension+2 more
Changi General Hospital 120
Not applicableLooking for participantsNCT06735118
What this trial is testing

Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Yunnan Cancer Hospital 120
Not applicableStudy completedNCT06095479
What this trial is testing

Ultrasound Liver Fat Quantification on Pediatric Patients

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Philips (China) Investment CO., LTD 90
Not applicableLooking for participantsNCT05870969
What this trial is testing

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

Who this might be right for
Carcinoma, HepatocellularHepatitis C, ChronicHepatitis B, Chronic+2 more
Ruijin Hospital 20,000
Not applicableNot Yet RecruitingNCT07834905
What this trial is testing

Nutritional Indices and Inflammatory Markers in MASLD

Who this might be right for
Liver FibrosisMalnutritionNon-Alcoholic Fatty Liver Disease
Assiut University 180
Early research (Phase 1)Study completedNCT04146805
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects

Who this might be right for
Chronic Liver DiseaseNASH - Nonalcoholic Steatohepatitis
Blade Therapeutics 80
Not applicableUnknownNCT01856465
What this trial is testing

Intestinal Microbiota and NAFLD Pre and Post Bariatric Surgery

Who this might be right for
Morbid ObesityNon-alcoholic Fatty Liver Disease
Johane Allard 120
Post-approval studies (Phase 4)Study completedNCT02649465
What this trial is testing

SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD

Who this might be right for
Non-alcoholic Fatty Liver Disease
Kanazawa University 40
Early research (Phase 1)WithdrawnNCT02457286
What this trial is testing

Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Northwell Health
Not applicableStudy completedNCT04509245
What this trial is testing

The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesFatty Liver, Nonalcoholic
German Diabetes Center 24
Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Not applicableUnknownNCT05120557
What this trial is testing

Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH

Who this might be right for
Liver DiseasesLiver CirrhosisNASH - Nonalcoholic Steatohepatitis+3 more
E-Scopics 1,000
Not applicableStudy completedNCT02461212
What this trial is testing

Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth

Who this might be right for
Non-alcoholic Fatty Liver Disease
Emory University 50
Next Page